Status:

RECRUITING

A Phase I Clinical Study of SSS59 Monotherapy in Patients With Advanced Malignant Tumors

Lead Sponsor:

Shenyang Sunshine Pharmaceutical Co., LTD.

Conditions:

Malignant Tumors

Eligibility:

All Genders

18-75 years

Phase:

PHASE1

Brief Summary

This study was an open-label phase I study to evaluate the safety, pharmacokinetics, and antitumor activity of SSS59 as a single agent in patients with advanced malignancies.

Detailed Description

This study includes 4 Parts: Part A1 (dose escalation and dose extension for QW administration), Part A2 (dose escalation and dose extension for Q2W administration), Part A3 (dose extension for Q3W ad...

Eligibility Criteria

Inclusion

  • Histologically and/or cytologically documented local advanced or recurrent or metastatic malignancies.
  • Eastern Cooperative Oncology Group (ECOG) performance status of 0-1.
  • Expected survival \>3 months.
  • Signed informed consent form.
  • Must have adequate organ function.

Exclusion

  • Any remaining AEs \> grade 1 from prior anti-tumor treatment as per CTCAE v5. 0, with exception of hair loss and fatigue.
  • Pregnant or nursing women or women/men who are ready to give birth.
  • symptomatic central nervous system metastasis.
  • Allergy to other antibody drugs or any excipients in the study drugs.
  • Underwent major surgery within 4 weeks prior to first dosing.
  • The patient is participating in another clinical study, unless it is an observational (non-intervention) clinical study or a follow-up period of an intervention study.
  • The above information was not intended to contain all considerations relevant to a participant's potential participation in a clinical trial.

Key Trial Info

Start Date :

April 27 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2027

Estimated Enrollment :

154 Patients enrolled

Trial Details

Trial ID

NCT06944444

Start Date

April 27 2025

End Date

December 31 2027

Last Update

April 29 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Shanghai First People's Hospital

Shanghai, Shanghai Municipality, China